Please provide your email address to receive an email when new articles are posted on . The Open-Motion device will undergo a future validation study to further determine its viability. Large vessel ...

Recent developments of interest in cardiovascular medicine ...

HELSINKI — In patients with large vessel occlusion stroke treated within 4.5 hours of symptom onset, outcomes were better in those who received the thrombolytic tenecteplase prior to endovascular ...

Please provide your email address to receive an email when new articles are posted on . Women were less likely to return to work after large vessel occlusion stroke compared with men, despite similar ...

The benefit of endovascular therapy in the treatment of stroke caused by an occlusion of the basilar artery has finally been confirmed in the ATTENTION randomized trial. The study, conducted in China, ...

Current guidelines restrict intravenous thrombolysis to a short window after stroke onset. Advances in perfusion imaging, however, now allow identification of patients with salvageable brain tissue ...

Stroke is the leading cause of disability worldwide and the second leading cause of death, but the right early intervention can prevent severe consequences. A new study led by investigators from ...

A decision model found that the relative clinical benefit of left atrial appendage occlusion (LAAO) and oral anticoagulants (OAC) in patients with atrial fibrillation depends on the patients' baseline ...

Ninety-day mortality was 5.0 and 3.2% with tenecteplase and standard medical treatment, respectively. HealthDay News — For patients with non-large vessel occlusion acute ischemic stroke and ...

Intracranial angioplasty again failed for less severe intracranial atherosclerotic stenosis (ICAS) strokes in a Chinese trial. However, a separate analysis did leave a glimmer of hope that IV ...